Harmonised classification and labelling current consultations
Comments from parties concerned
Parties concerned are invited to submit their comments to the proposed harmonised classification and labelling (CLH) of the substance. The CLH public consultation lasts for 45 days and the comments received will be published regularly on the ECHA website during the consultation period. At the end of the public consultation round, the comments received are compiled into a list that will be part of the Opinion of the Committee for Risk Assessment (RAC).
After this public consultation, the parties concerned are encouraged to coordinate their involvement in the RAC opinion-making process with the regular and sector-specific stakeholder observers. The list of these stakeholders, the working procedure for their participation in the RAC meeting as well as the relevant agendas are available below. The agendas indicate the substances planned to be discussed at each RAC meeting.
Identification of parties concerned
Following the public consultation, ECHA may need to contact parties concerned in order to discuss specific issues related to the CLH of the substance. Thus, ECHA encourages parties concerned to provide their contact details in the public consultation comments webform.
Comments on endpoints
RAC may consider another category more appropriate for the classification of the substance after examining the available information. You are therefore also invited to submit comments supporting the proposed classification or proposal to not classify, and if you have additional information not related to the proposed classification.
Write your comments in English, if possible.
| Substance Name | EC Number | CAS Number | Deadline for comments | |
|---|---|---|---|---|
| Boric acid | 233-139-2 | 10043-35-3 | 28/06/2013 | |
| disodium octaborate, anhydrate | 234-541-0 | 12008-41-2 | 14/06/2013 | |
| disodium octaborate, tetrahydrate | 234-541-0 | 12280-03-4 | 14/06/2013 | |
| fenpyroximate (ISO); tert-butyl 4-[({[(E)-(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate | - | 134098-61-6 | 14/06/2013 | |
| lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione | 218-499-0 | 2164-08-1 | 28/06/2013 |
Showing 5 results.
Publication of the outcome of the CLH process
Pursuant to Art. 37(4) of the CLP Regulation, RAC shall adopt an opinion on any CLH proposal submitted within 18 months of receipt of the proposal, giving the parties concerned the opportunity to comment. The RAC opinion has annexed a background document and a response to comments table (RCOM) based on the comments from the public consultation. When the RAC opinion is adopted, it shall be published on ECHA's website together with the background document and RCOM. ECHA shall forward the RAC opinion and any comments to the Commission. Where the Commission finds that the CLH of the substance is appropriate, it shall submit a draft decision concerning the inclusion of that substance in Part 3 of Annex VI to the CLP Regulation (Art. 37(5) CLP Regulation)
Following the inclusion of the substance in Part 3 of Annex VI to the CLP Regulation, all manufacturers, importers and users of the substance in the EU shall classify the substance accordingly, enabling the ultimate users to be better informed about the substance, its potential effects and how best to make use of it safely. The list of harmonised classifications and labelling of hazardous substances may be consulted on this website at the link below.
Confidentiality
All non-confidential information submitted during the public consultation will be made available to Member State competent authorities (MSCAs), dossier submitters, RAC members, accredited stakeholders and the RAC and ECHA Secretariats. The comments will appear on the ECHA website during the public consultation. Following the adoption of the RAC opinion, ECHA will publish the compiled comments on its website, including the non-confidential attachments received and the response to the comments.
If you choose to submit information that you claim to be confidential, this will be available only to ECHA, its Committees, and the dossier submitter. In this case, we kindly ask you to submit a non-confidential version of the information so that if needed this could be made publicly available. Further practical instructions on the submission of the information are provided in the public consultation comments webform.